FLT3 and acute myeloid leukemia: The aim of this study was to assess whether (i) FLT3-ITD allelic ratio (AR) and ITD mutation length and/or (ii) transcriptomic features, are associated with ex vivo and clinical responses to FLT3 inhibitors in adult AML.